Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

FDA approves Reblozyl to treat anemia in MDS

April 6, 2020

FDA approves Sevenfact for hemophilia A and B

April 2, 2020

FORMA Therapeutics identifies new pyruvate kinase PKLR activators

April 2, 2020

FDA accepts IND application for OTQ-923

April 2, 2020

FDA approves new intravenous formulation of Triferic

March 30, 2020

Otsuka Pharmaceutical identifies AhR antagonists

March 25, 2020

Desmopressin shows promise for the management of bleeding in rectal cancer

March 20, 2020

Cellphire cleared to begin phase II study of Thrombosomes in bleeding patients with thrombocytopenia

March 19, 2020

Novo Nordisk announces decision to pause concizumab trials in hemophilia

March 17, 2020

Keeping stem cells quiescent enables greater ultimate potency

March 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...